{"id":"NCT01081912","sponsor":"Zogenix, Inc.","briefTitle":"Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain","officialTitle":"A Randomized Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Tolerability and Safety of Hydrocodone Bitartrate Controlled-Release Capsules in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2011-10","completion":"2011-10","firstPosted":"2010-03-05","resultsPosted":"2014-04-21","lastUpdate":"2022-12-08"},"enrollment":510,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Back Pain Lower Back Chronic"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":["Sugar pill"]},{"type":"DRUG","name":"Hydrocodone bitartrate","otherNames":[]}],"arms":[{"label":"Hydrocodone Bitartrate Capsules","type":"ACTIVE_COMPARATOR"},{"label":"Placebo comparator","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to evaluate the safety and efficacy of Hydrocodone Bitartrate controlled-release capsules in subjects with chronic low back pain.","primaryOutcome":{"measure":"Mean Change in 24-hour Pain Intensity Ratings Scale (NRS).","timeFrame":"Baseline to Day 85 (Treatment Phase)","effectByArm":[{"arm":"Hydrocodone Bitartrate Capsules","deltaMin":0.48,"sd":1.563},{"arm":"Placebo Comparator","deltaMin":0.96,"sd":1.55}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":10},"locations":{"siteCount":51,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":510},"commonTop":["Constipation","Nausea","Somnolence","Fatigue","Diarrhoea"]}}